These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 12501313)

  • 21. In-vitro activity of 5-fluorocytosine against 1,021 Spanish clinical isolates of Candida and other medically important yeasts.
    Quindós G; Ruesga MT; Martín-Mazuelos E; Salesa R; Alonso-Vargas R; Carrillo-Muñoz AJ; Brena S; San Millán R; Pontón J
    Rev Iberoam Micol; 2004 Jun; 21(2):63-9. PubMed ID: 15538829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An emerging issue of mixed yeast cultures.
    Yang YL; Chu WL; Lin CC; Tsai SH; Chang TP; Lo HJ
    J Microbiol Immunol Infect; 2014 Aug; 47(4):339-44. PubMed ID: 23523053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emergence of non-Candida albicans species: Epidemiology, phylogeny and fluconazole susceptibility profile.
    Sadeghi G; Ebrahimi-Rad M; Mousavi SF; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M
    J Mycol Med; 2018 Mar; 28(1):51-58. PubMed ID: 29366545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid and unequivocal differentiation of Candida dubliniensis from other Candida species using species-specific DNA probes: comparison with phenotypic identification methods.
    Ellepola AN; Hurst SF; Elie CM; Morrison CJ
    Oral Microbiol Immunol; 2003 Dec; 18(6):379-88. PubMed ID: 14622344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isavuconazole, micafungin, and 8 comparator antifungal agents' susceptibility profiles for common and uncommon opportunistic fungi collected in 2013: temporal analysis of antifungal drug resistance using CLSI species-specific clinical breakpoints and proposed epidemiological cutoff values.
    Pfaller MA; Rhomberg PR; Messer SA; Jones RN; Castanheira M
    Diagn Microbiol Infect Dis; 2015 Aug; 82(4):303-13. PubMed ID: 25986029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
    Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC
    J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diversity of commensal yeasts within and among healthy hosts.
    Kam AP; Xu J
    Diagn Microbiol Infect Dis; 2002 May; 43(1):19-28. PubMed ID: 12052625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Occurrence and diversity of yeasts in the mangrove ecosystems in fujian, guangdong and hainan provinces of china.
    Chi ZM; Liu TT; Chi Z; Liu GL; Wang ZP
    Indian J Microbiol; 2012 Sep; 52(3):346-53. PubMed ID: 23997323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Yeast communities as descriptors of habitat use by the Drosophila fasciola subgroup (repleta group) in Atlantic rain forests.
    Morais PB; Rosa CA; Hagler AN
    Oecologia; 1995 Sep; 104(1):45-51. PubMed ID: 28306912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing.
    Pfaller MA; Diekema DJ; Gibbs DL; Newell VA; Meis JF; Gould IM; Fu W; Colombo AL; Rodriguez-Noriega E;
    J Clin Microbiol; 2007 Jun; 45(6):1735-45. PubMed ID: 17442797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Investigation of antifungal susceptibilities and some virulence factors of Candida strains isolated from blood cultures and genotyping by RAPD-PCR].
    Gültekin B; Eyigör M; Tiryaki Y; Kırdar S; Aydın N
    Mikrobiyol Bul; 2011 Apr; 45(2):306-17. PubMed ID: 21644074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antifungal susceptibility testing results of New Zealand yeast isolates, 2001-2015: Impact of recent CLSI breakpoints and epidemiological cut-off values for Candida and other yeast species.
    Morris AJ; Rogers K; McKinney WP; Roberts SA; Freeman JT
    J Glob Antimicrob Resist; 2018 Sep; 14():72-77. PubMed ID: 29486358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isavuconazole MIC distribution of 29 yeast species responsible for invasive infections (2015-2017).
    Desnos-Ollivier M; Bretagne S; Boullié A; Gautier C; Dromer F; Lortholary O;
    Clin Microbiol Infect; 2019 May; 25(5):634.e1-634.e4. PubMed ID: 30771532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Yeast communities of the cactus Pilosocereus arrabidae and associated insects in the Sandy coastal plains of southeastern Brazil.
    Rosa CA; Morais PB; Hagler AN; Mendonça-Hagler LC; Monteiro RF
    Antonie Van Leeuwenhoek; 1994; 65(1):55-62. PubMed ID: 8060124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo pathogenicity of eight medically relevant Candida species in an animal model.
    Arendrup M; Horn T; Frimodt-Møller N
    Infection; 2002 Oct; 30(5):286-91. PubMed ID: 12382088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Presumptive identification of Candida species other than C. albicans, C. krusei, and C. tropicalis with the chromogenic medium CHROMagar Candida.
    Hospenthal DR; Beckius ML; Floyd KL; Horvath LL; Murray CK
    Ann Clin Microbiol Antimicrob; 2006 Jan; 5():1. PubMed ID: 16390552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Opportunistic yeast infections and enzymatic profile of the etiological agents].
    Macêdo DP; Farias AM; Lima Neto RG; Silva VK; Leal AF; Neves RP
    Rev Soc Bras Med Trop; 2009; 42(2):188-91. PubMed ID: 19448940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evaluation of a new method for antifungal drugs susceptibility testing to yeasts].
    Ishigaki S; Kawakami S; Ono Y; Miyazawa Y
    Kansenshogaku Zasshi; 2000 Mar; 74(3):221-30. PubMed ID: 10783576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid identification of Candida species and other clinically important yeast species by flow cytometry.
    Page BT; Kurtzman CP
    J Clin Microbiol; 2005 Sep; 43(9):4507-14. PubMed ID: 16145099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and antifungal susceptibility of a large collection of yeast strains isolated in Tunisian hospitals.
    Eddouzi J; Lohberger A; Vogne C; Manai M; Sanglard D
    Med Mycol; 2013 Oct; 51(7):737-46. PubMed ID: 23768242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.